Osteosarcoma Symptoms: Early Signs, Red Flags & When to Seek Care

What Is Osteosarcoma?

Osteosarcoma is the most common primary malignant bone tumor in children, adolescents, and young adults (peak 10–25 years). It arises from primitive bone-forming mesenchymal cells and most often occurs in the metaphysis of long bones: distal femur, proximal tibia, proximal humerus.

Common Presenting Symptoms

  • Bone pain: Deep, aching, often in knee, thigh, or arm. Initially intermittent, activity-related; becomes constant, night pain as tumor grows.
  • Swelling/palpable mass: Firm, tender, progressively enlarging over weeks–months. May be warm.
  • Limited range of motion: If near joint (knee, shoulder).
  • Limping: Due to pain or mechanical obstruction (femoral/tibial tumors).
  • Pathologic fracture: Fracture through tumor-weakened bone with minimal/no trauma (10–15% at presentation).
  • Systemic symptoms (late): Weight loss, fatigue, fever (rare).
  • Neurologic deficits: Rare; if tumor compresses nerves (e.g., sciatic nerve with proximal femoral tumor).

Red Flags Requiring Urgent Imaging

  • Persistent bone pain >2–3 weeks, especially night pain
  • Unexplained limp in child/adolescent
  • Palpable mass near joint
  • Pathologic fracture
  • Pain unresponsive to NSAIDs/rest

Diagnostic Workup

  1. Plain radiographs (AP + lateral): Sunburst periosteal reaction, Codman's triangle, osteolytic/sclerotic destruction, soft tissue extension.
  2. MRI (whole bone): Local extent, marrow skip lesions, neurovascular involvement — essential for surgical planning.
  3. Chest CT: Staging for pulmonary metastases (most common site).
  4. Bone scan or PET-CT: Detect bony metastases/skip lesions.
  5. Biopsy: Core needle (image-guided) by surgeon who will do resection. Confirms diagnosis, grade, subtype.
  6. Labs: ALP, LDH (prognostic); CBC, renal/hepatic function.

Treatment & Prognosis

  • Neoadjuvant chemotherapy (MAP regimen: high-dose methotrexate, doxorubicin, cisplatin) → wide surgical resection (limb-salvage or amputation) → adjuvant chemo.
  • 5-year survival: ~70% localized; ~20–30% metastatic at diagnosis.
  • Good histologic response (>90% necrosis) → better prognosis.

Key Message

Bone pain in a teenager—especially at night or with a palpable mass—is osteosarcoma until proven otherwise. Early referral to a sarcoma center improves limb salvage and survival.

Osteoporosis - Related Articles